Glucodynamix diabetes interventions

A new type of automated diabetes technology has now delivered over 125,000 interventions that apparently raise the bar for interventional healthcare . But what exactly is Glucodynamix? How does it work?
This new type of healthcare has been subjected to many clinical trials over the last five years, involving top physicians, researchers, diabetics and diabetic care teams . The president and CEO of Diabetech, the company who make and market Glucodynamix, Kevin McMaho, has the following to say:
“GlucoDYNAMIX represents an entirely new category of healthcare information technology. Looking across the board at pharma trials, clinical management and patient self-management, virtually everything out there is just now talking about moving to web -based data distribution versus the cumbersome cabled PC application. The key to enabling desperately needed improved outcomes isn’t merely changing the location of stored patient data from the medical device to the PC or on the Web. Rather, it’s about empowering patients, their social networks and simultaneously increasing the caring capacity and effectiveness of an overworked and inefficient healthcare system .”
Interventions are delivered to the patient in a variety of different forms, including via text messaging, ambient displays, telephone calls, emails, and others. The skill is in knowing when and how to intervene. Diabetech claim a 98 per cent satisfaction rating from all trial participants, a result that means that intervention healthcare could grow in the future .